This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International
September 15-18, 2025
Hynes Convention CenterBoston, USA
Register For Passes Today
Menu
Book Now
Key Sessions
Fouad Atouf
PLENARY KEYNOTE: Evolving Pharmacopeial Standards to Shape the Future of Biological Medicines
US Pharmacopeia
Amy Shaw
Scale-Out Versus Scale-Up Strategies for Maximizing Cellular Therapies
Takeda, USA
Kelvin Lee
KEYNOTE: The Future of Biopharmaceutical Manufacturing: Innovation and Collaboration
NIIMBL
keyboard_arrow_right

Wednesday 17th September - Main Conference Day Two - ET (Eastern Time, GMT-05:00)

keyboard_arrow_leftSearch & Filter
search
Wednesday 17th September - Main Conference Day Two - ET (Eastern Time, GMT-05:00)
search
Showing 1 of 1 Streams
8:50am - 9:00am
Chairperson’s Opening Remarks: Development of Emerging Cell & Gene Therapies
  • Christopher Bravery, Ph.D. - Consulting Regulatory Scientist, Advbiols
9:00am - 9:30am
Accelerate Manufacturability and Personalize Therapies with Confidential Collaboration
  • Kat Kozyrytska - Consultant, AI Implementation & Tech Commercialization
9:30am - 10:00am
Redosable DNA Delivery Systems Designed by Machine Learning
  • Shashi Murthy, PhD - CTO and Co-Founder, Nanite Inc.
10:00am - 10:30am
Efficient and Liver-Detargeted In Vivo Multiplex Gene Editing of Human Hematopoietic Stem and Progenitor Cells
  • Pauline Schmit - Senior Scientist, nChroma Bio
Showing 1 of 1 Streams
11:30am - 12:00pm
Leveraging Gene Editing Technologies for Precision and Efficiency in Cell and Gene Therapy Development
  • Kristy Wood, PhD - SVP, Technical Operations, Intellia Therapeutics
12:00pm - 12:30pm
Expanding Gene Editing Beyond The Liver
  • Devyn Smith - CEO, Arbor Biotechnologies
12:30pm - 1:00pm
Scalable Mixing for Small-Volume GMP Applications: Introducing the 10 L LevMixer™ System
  • Saadia Zakai - Senior Global Product Manager – Single Use Mixing, Cytiva
  • Nagaraj Rao - Principal Analysis and Modelling Engineer, Cytiva
Showing 1 of 1 Streams
2:10pm - 2:15pm
Chairperson’s Opening Remarks: Development of Emerging Cell & Gene Therapies
  • Mark Farmery - Chief Development Officer, Anocca AB
2:15pm - 2:45pm
Single-Reaction rAAV Genomic Titer, Capsid, and Empty/Full Analysis Using the BioRad VeriCheck ddPCR Kit
  • Stephen Ollosi - Director, Molecular Biology, Jaguar Gene Therapy
2:45pm - 3:15pm
Prime Editor Lipid Nanoparticles: From Development to Scalable Manufacturing
  • Weiyi Li - Senior Manager, LNP Formulation, Prime Medicine
3:15pm - 3:45pm
Shrinking the Timeline: Reaching the Clinic in Record Time with Innovative CRISPR mRNA Manufacturing Solutions
  • Max Sellman - Senior Product Manager, Gene Editing, Aldevron
Showing 1 of 1 Streams
4:30pm - 5:30pm
Panel Discussion: Cell and Gene Therapy CDMO Selection and External Manufacturing Best Practices
  • Shankar Swaminathan, PhD - Team Lead, Associate Director Drug Product Development, Astellas Institute for Regenerative Medicine
  • D.J. Harkins - Director, External Manufacturing and Supply, Takeda
  • Maura Hobson - Executive Director, External Manufacturing, Sana Biotechnology
  • Khandan Baradaran - Consulting Leader & Strategic Advisor, PLG North America/Halloran
Tuesday 16th September - Main Conference Day One
NextThursday 18th September - Main Conference Day Three
Filter
Streams
Clear
Choose Day